This suggests that CTSD represents a common molecular pathology amongst both short- and long-lived ALS patients, while increases in UCHL1 and GPNMB in short-lived represent more aggressive molecular etiologies. This evidence concerns the gene GPNMB and amyotrophic lateral sclerosis.